Edition:
United States

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.00USD
15 Dec 2017
Change (% chg)

$-0.10 (-3.23%)
Prev Close
$3.10
Open
$3.10
Day's High
$3.10
Day's Low
$3.00
Volume
119,914
Avg. Vol
50,109
52-wk High
$4.20
52-wk Low
$2.45

Select another date:

Wed, Dec 6 2017

BRIEF-Highbridge Capital Reports 5.55 Pct Passive Stake In Adverum Biotechnologies

* HIGHBRIDGE CAPITAL MANAGEMENT LLC REPORTS 5.55 PERCENT PASSIVE STAKE IN ADVERUM BIOTECHNOLOGIES INC AS OF DECEMBER 5 - SEC FILING Source text for Eikon: (http://bit.ly/2iwSEnw) Further company coverage:

BRIEF-Adverum Begins Patient Enrollment In Advance Phase 1/2 Clinical Trial

* ADVERUM BIOTECHNOLOGIES BEGINS PATIENT ENROLLMENT IN THE ADVANCE PHASE 1/2 CLINICAL TRIAL FOR A1AT DEFICIENCY

BRIEF-‍Adage Capital Partners Reports A 5.55 Percent Passive Stake In Adverum Biotechnologies As Of Nov 17, 2017

* ‍ADAGE CAPITAL PARTNERS GP, L.L.C REPORTS A 5.55 PERCENT PASSIVE STAKE IN ADVERUM BIOTECHNOLOGIES INC AS OF NOVEMBER 17, 2017 - SEC FILING​ Source text: (http://bit.ly/2hXgpom) Further company coverage:

BRIEF-Adverum Biotechnologies posts Q3 loss of $0.32 per share

* Adverum biotechnologies reports third quarter 2017 financial results and provides corporate update

BRIEF-Adverum Biotechnologies says has increased size of board to eight members

* Adverum Biotechnologies Inc - increased size of board to eight members - SEC filing Source text: [http://bit.ly/2eKPWc0] Further company coverage:

BRIEF-Adverum Biotechnologies files for mixed shelf of up to $150 mln

* Adverum Biotechnologies Inc files for mixed shelf of up to $150 million - ‍​sec filing Source text: (http://bit.ly/2wyLc11) Further company coverage:

BRIEF-Adverum Biotechnologies Q2 loss per share $0.27

* Adverum Biotechnologies reports second quarter 2017 financial results and provides update

Select another date: